The results showed that ISM1 overexpression had a better performance in CRC patients with the following characteristics: ≥60 (years), male, T3–4, negative lymph nodes, and prior malignancy, and all of these patients exhibited a shorter OS (Supplementary Figure 2). Here, ISM1 is linked to colorectal carcinoma.